Cancer Prevention and Research Institute of Texas logo

Cancer Prevention and Research Institute of Texas

North America, Texas, United States, Austin

Description

Cancer Prevention and Research Institute of Texas is a state agency that invests in cancer prevention and academic research.

Investor Profile

Cancer Prevention and Research Institute of Texas has made 50 investments, with 7 in the past 12 months and 78% as lead.

Stage Focus

  • Grant (90%)
  • Series B (2%)
  • Post Ipo Debt (2%)
  • Post Ipo Equity (2%)
  • Series A (2%)
  • Series Unknown (2%)

Country Focus

  • United States (90%)
  • Canada (6%)
  • Germany (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Education
  • Life Science
  • Biopharma
  • Oncology
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cancer Prevention and Research Institute of Texas frequently co-invest with?

Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
GOOSE Capital
North America, Texas, United States, Houston
Co-Investments: 1
Houston Angel Network
North America, Texas, United States, Houston
Co-Investments: 1
GenHenn Venture
North America, New Jersey, United States, Cranbury
Co-Investments: 1
TV
North America, Texas, United States, Houston
Co-Investments: 1
cultivate(MD)
North America, Michigan, United States, Holland
Co-Investments: 1
AngelMD
North America, Colorado, United States, Denver
Co-Investments: 1

What are some of recent deals done by Cancer Prevention and Research Institute of Texas?

Ypsilon Therapeutics

Waltham, Massachusetts, United States

Ypsilon Therapeutics develops T cell receptor mimics(TCRm) against validated tumor antigens.

Health CareMedicalTherapeutics
GrantJan 30, 2025
Amount Raised: $2,700,000
Marker Therapeutics

Minneapolis, Minnesota, United States

Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

BiotechnologyTherapeutics
GrantDec 17, 2024
Amount Raised: $9,500,000
Eisbach Bio

Munich, Bayern, Germany

Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.

Biotechnology
GrantNov 26, 2024
Amount Raised: $4,750,000
Barricade Therapeutics

Fort Worth, Texas, United States

Barricade Therapeutics is a privately held biotech company.

Biotechnology
GrantNov 22, 2024
Amount Raised: $14,005,035
Prana Thoracic

Houston, Texas, United States

Prana Thoracic is a medical devices company that develops solutions for the early detection and intervention of lung cancer.

Health CareMedicalMedical Device
Series AJun 18, 2024
Amount Raised: $3,000,000
7 Hills Pharma

Houston, Texas, United States

7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.

Health CarePharmaceutical
GrantJun 3, 2024
Amount Raised: $4,700,000
Indapta Therapeutics

San Francisco, California, United States

Indapta Therapeutics is a privately held biotechnology company.

BiopharmaBiotechnologyMedical
GrantMay 21, 2024
Amount Raised: $4,500,000
Allterum Therapeutics

Houston, Texas, United States

Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.

BiopharmaBiotechnologyHealth Care
GrantApr 8, 2024
Amount Raised: $12,000,000

The University of Texas Health Science Center at San Antonio serves San Antonio and the 50,000 square-mile area of South Texas.

EducationHealth CareMedical
GrantMar 7, 2024
Amount Raised: $16,400,000
Gradalis

Carrollton, Texas, United States

Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.

BiotechnologyHealth DiagnosticsManufacturing
GrantNov 16, 2023
Amount Raised: $9,900,000